Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Primer on Imaging in Myositis

Rochelle Castillo, MD, MS, Andro Licaros, MD, & Jemima Albayda, MD  |  Issue: November 2022  |  November 9, 2022

In medicine, as in advertising, pictures can be worth a thousand words. From arthritis to vasculitis, imaging studies have been variably employed to aid in the diagnosis, treatment, risk stratification and prognostication of patients with rheumatic and musculoskeletal disorders. The same holds true with the idiopathic inflammatory myopathies (IIM), in which the clinical utility is high, despite the absence of imaging as a diagnostic variable in the latest European League Against Rheumatism (EULAR)/ACR classification criteria.1

These criteria—intended for research classification purposes and not diagnosis—took into account the availability of specific tests, and magnetic resonance imaging (MRI), the gold standard imaging modality for muscle, is not available in all regions. Nevertheless, imaging remains of particular importance in IIM because it provides an assessment of structural abnormalities in muscle tissue, which can help confirm the presence of disease, delineate the type and pattern of its involvement and, ultimately, help guide treatment.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

MRI: Myositis Routine Imaging?

MRI provides excellent soft tissue resolution and contrast, allowing for the evaluation of the extent and distribution of edema, fatty/fibrous replacement and atrophy, and is the main workhorse when it comes to muscle imaging. It is useful for diagnostic purposes to confirm muscle involvement in a patient with suspected disease and can pinpoint potentially high-yield sites for muscle biopsy, albeit not in real time. In some instances, it can help differentiate among the IIM subgroups based on muscles involved and distinguish them from common mimics (see Table 1).

Click to enlarge.

The MRI myositis protocol involves T1-weighted imaging (T1W) and fluid-sensitive T2W with fat suppression or short-tau inversion recovery (STIR) sequence in the axial and coronal planes.2,3 Gadolinium contrast is not required unless fasciitis, focal myositis or a cystic or solid mass lesion are of primary concern.4 In IIM-affected muscle, T2W and STIR hyperintensities depict edema and increased water content characteristic of active muscle inflammation or necrosis in the acute phase (see Figure 1B). T1W hyperintensities delineate fatty replacement which is a marker of damage and chronicity (see Figure 1A). Calcinosis can be detected on all sequences as signal voids (see Table 1).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A whole-body MRI would be ideal in that it can yield precise patterns of preferential muscle involvement or sparing, making it possible to detect disease-specific muscle signatures or fingerprints. Clinically, however, it is time consuming and cost inefficient. Thus, an MRI of the thigh or of the upper extremity is typically employed, and generally sufficient, for the evaluation of IIMs. In the same vein, while higher magnetic strengths may yield crisper images, the 1.5 Tesla (1.5T) MRI does not appear to fare worse than the 3.0T for the purposes of MSK imaging.5

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsMyositis Tagged with:dermatomyositisMagnetic resonance imaging (MRI)myositispositron emission tomography (PET)Ultrasound

Related Articles

    Myositis Mysteries

    January 1, 2008

    Why isn’t my myositis patient getting better?

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    From Strength to Strength: Idiopathic Inflammatory Myopathy Diagnosis & Management

    December 2, 2021

    During the ACR Convergence 2021 Review Course, Rohit Aggarwal, MD, MS, provided an update on idiopathic inflammatory myopathy.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences